Literature DB >> 3110070

In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.

R S Berk, D Brown, I Coutinho, D Meyers.   

Abstract

Two phospholipase C fractions were detected in culture supernatants from Pseudomonas aeruginosa ATCC 19660, PAO1, and D10C by preparative polyacrylamide gel electrophoresis. Both hemolytic fractions from strain ATCC 19660 were isolated by polyacrylamide gel electrophoresis and were found to cause paralysis, death, dermonecrosis, footpad swelling, and vascular permeability in mice. In vivo toxicity was directly associated with enzymatic activity.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3110070      PMCID： PMC260587          DOI： 10.1128/iai.55.7.1728-1730.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  Toxin inhibitors of protein synthesis: production, purification, and assay of Pseudomonas aeruginosa toxin A.

Authors:  B H Iglewski; J C Sadoff
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  The biochemistry of bacterial toxins: The lecithinase activity of Cl. welchii toxins.

Authors:  M G Macfarlane; B C Knight
Journal:  Biochem J       Date:  1941-09       Impact factor: 3.857

3.  Phospholipase C assay using p-nitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme.

Authors:  S Kurioka; M Matsuda
Journal:  Anal Biochem       Date:  1976-09       Impact factor: 3.365

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  A procedure to increase the sensitivity of staining by Coomassie brilliant blue G250-perchloric acid solution.

Authors:  I B Holbrook; A G Leaver
Journal:  Anal Biochem       Date:  1976-10       Impact factor: 3.365

6.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

7.  Production of phospholipase C (alpha-toxin), haemolysins and lethal toxins by Clostridium perfringens types A to D.

Authors:  R Möllby; T Holme; C E Nord; C J Smyth; T Wadström
Journal:  J Gen Microbiol       Date:  1976-09

8.  Purification and characterization of leucocidin from Pseudomonas aeruginosa.

Authors:  W Scharmann
Journal:  J Gen Microbiol       Date:  1976-04

9.  In Vivo Studies with the Partially Purified Protease (Elastase) from Pseudomonas aeruginosa.

Authors:  G Meinke; J Barum; B Rosenberg; R Berk
Journal:  Infect Immun       Date:  1970-11       Impact factor: 3.441

10.  Production of C2 toxin by Clostridium botulinum types C and D as determined by its vascular permeability activity.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441
View more
  14 in total

1.  Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity.

Authors:  L S Terada; K A Johansen; S Nowbar; A I Vasil; M L Vasil
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent.

Authors:  D J Meyers; R S Berk
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Synthesis and secretion of phospholipase C by oral spirochetes.

Authors:  R Siboo; W al-Joburi; M Gornitsky; E C Chan
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

4.  Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients.

Authors:  U Bergmann; J Scheffer; M Köller; W Schönfeld; G Erbs; F E Müller; W König
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Cloning and expression of the phospholipase C gene from Clostridium perfringens and Clostridium bifermentans.

Authors:  J Y Tso; C Siebel
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

6.  Characterization of Pseudomonas aeruginosa growth on O-acylcarnitines and identification of a short-chain acylcarnitine hydrolase.

Authors:  Jamie A Meadows; Matthew J Wargo
Journal:  Appl Environ Microbiol       Date:  2013-03-22       Impact factor: 4.792

7.  GbdR regulates Pseudomonas aeruginosa plcH and pchP transcription in response to choline catabolites.

Authors:  Matthew J Wargo; Tiffany C Ho; Maegan J Gross; Laurie A Whittaker; Deborah A Hogan
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

8.  Serum antibody response to Pseudomonas aeruginosa antigens during corneal infection.

Authors:  M J Preston; J M Berk; L D Hazlett; R S Berk
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

9.  Mutations in the hemolytic-phospholipase C operon result in decreased virulence of Pseudomonas aeruginosa PAO1 grown under phosphate-limiting conditions.

Authors:  R M Ostroff; B Wretlind; M L Vasil
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion.

Authors:  J L Kadurugamuwa; T J Beveridge
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.